X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs BIOCON LTD - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD BIOCON LTD WYETH LTD/
BIOCON LTD
 
P/E (TTM) x 27.7 36.7 75.4% View Chart
P/BV x 5.3 4.9 109.5% View Chart
Dividend Yield % 1.3 1.5 84.1%  

Financials

 WYETH LTD   BIOCON LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
BIOCON LTD
Mar-16
WYETH LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,044496 210.7%   
Low Rs818397 206.3%   
Sales per share (Unadj.) Rs298.6174.3 171.3%  
Earnings per share (Unadj.) Rs57.244.8 127.8%  
Cash flow per share (Unadj.) Rs58.456.9 102.6%  
Dividends per share (Unadj.) Rs17.005.00 340.0%  
Dividend yield (eoy) %1.81.1 162.9%  
Book value per share (Unadj.) Rs249.5202.8 123.0%  
Shares outstanding (eoy) m22.72200.00 11.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.12.6 121.8%   
Avg P/E ratio x16.310.0 163.4%  
P/CF ratio (eoy) x15.97.8 203.4%  
Price / Book Value ratio x3.72.2 169.7%  
Dividend payout %29.711.2 266.1%   
Avg Mkt Cap Rs m21,15789,220 23.7%   
No. of employees `0000.54.4 11.1%   
Total wages/salary Rs m4006,363 6.3%   
Avg. sales/employee Rs Th13,787.47,894.5 174.6%   
Avg. wages/employee Rs Th813.01,441.2 56.4%   
Avg. net profit/employee Rs Th2,643.32,029.7 130.2%   
INCOME DATA
Net Sales Rs m6,78334,854 19.5%  
Other income Rs m353845 41.7%   
Total revenues Rs m7,13635,699 20.0%   
Gross profit Rs m1,6178,200 19.7%  
Depreciation Rs m272,423 1.1%   
Interest Rs m6102 5.4%   
Profit before tax Rs m1,9386,520 29.7%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-55,754 -0.1%   
Tax Rs m6322,569 24.6%   
Profit after tax Rs m1,3018,961 14.5%  
Gross profit margin %23.823.5 101.3%  
Effective tax rate %32.639.4 82.8%   
Net profit margin %19.225.7 74.6%  
BALANCE SHEET DATA
Current assets Rs m6,98439,932 17.5%   
Current liabilities Rs m2,05616,276 12.6%   
Net working cap to sales %72.667.9 107.0%  
Current ratio x3.42.5 138.5%  
Inventory Days Days9954 185.3%  
Debtors Days Days2486 27.8%  
Net fixed assets Rs m24439,101 0.6%   
Share capital Rs m2271,000 22.7%   
"Free" reserves Rs m5,44138,591 14.1%   
Net worth Rs m5,66840,556 14.0%   
Long term debt Rs m2520,724 0.1%   
Total assets Rs m7,90184,816 9.3%  
Interest coverage x353.364.9 544.2%   
Debt to equity ratio x00.5 0.9%  
Sales to assets ratio x0.90.4 208.9%   
Return on assets %16.510.7 154.7%  
Return on equity %22.922.1 103.8%  
Return on capital %34.019.0 179.4%  
Exports to sales %0.230.7 0.7%   
Imports to sales %36.320.4 178.3%   
Exports (fob) Rs m1510,717 0.1%   
Imports (cif) Rs m2,4657,105 34.7%   
Fx inflow Rs m1511,789 0.1%   
Fx outflow Rs m2,6778,393 31.9%   
Net fx Rs m-2,6623,396 -78.4%   
CASH FLOW
From Operations Rs m9235,264 17.5%  
From Investments Rs m317-9,540 -3.3%  
From Financial Activity Rs m-48110,867 -4.4%  
Net Cashflow Rs m7596,591 11.5%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.1 20.6 248.1%  
Indian inst/Mut Fund % 11.3 8.4 134.5%  
FIIs % 7.2 10.7 67.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 19.9 152.8%  
Shareholders   21,978 109,995 20.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PLETHICO PHARMA  DIVIS LABORATORIES  NOVARTIS  UNICHEM LAB  MERCK LTD  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS